Oncternal Therapeutics Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Kisner Daniel L

Carter Michael G

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Cost of Exit or Disposal Activities, Change in Directors, Officers or Compensation

Cost of Exit or Disposal Activities, Change in Directors, Officers or Compensation, Other Events

Provides Business Update and Announces Second Quarter 2024 Financial Results

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Scanned paper annual report submission